![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 9/64 | |
A61P 7/04 | |||
A61K 38/48 |
(11) | Number of the document | 2414517 |
(13) | Kind of document | T |
(96) | European patent application number | 10723842.0 |
Date of filing the European patent application | 2010-03-29 | |
(97) | Date of publication of the European application | 2012-02-08 |
(45) | Date of publication and mention of the grant of the patent | 2016-09-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2010/029064 |
Date | 2010-03-29 |
(87) | Number | WO 2010/117729 |
Date | 2010-10-14 |
(30) | Number | Date | Country code |
164886 P | 2009-03-30 | US |
(72) |
SINHA, Uma, US
LU, Genmin, US
CONLEY, Pamela B., US
|
(73) |
Portola Pharmaceuticals, Inc.,
270 East Grand Avenue Suite 22, South San Francisco California 94080,
US
|
(54) | ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME |
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME |